Tadalafil, commonly branded as Cialis, redefined ED solutions with a distinct 36-hour active window, allowing men flexibility and a relaxed approach to managing erectile dysfunction. Originally developed for cardiovascular purposes, this PDE5 inhibitor found its niche by enhancing blood flow through the inhibition of the PDE5 enzyme, responsible for restricting smooth muscle relaxation. Released in the U.S. by 2003, this drug's unique duration, coupled with options for daily and on-demand use, has provided an adaptable solution that suits varied lifestyles, becoming a preferred choice for those seeking convenience and efficacy.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Cialis 10 by Gentech Laboratories, consult with your doctor or healthcare professional.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.